212 related articles for article (PubMed ID: 33957315)
1. A proteomic analysis of urine biomarkers in autism spectrum disorder.
Wang Y; Zhang J; Song W; Tian X; Liu Y; Wang Y; Ma J; Wang C; Yan G
J Proteomics; 2021 Jun; 242():104259. PubMed ID: 33957315
[TBL] [Abstract][Full Text] [Related]
2. Serum Proteomic Analysis by Nanoflow LC-MS/MS-Based Proteomics in IgA Chronic Kidney Disease.
Xue D; Li M; Xiang D; Sun J; Zhang W; Duan J; Cheng X; Wang C
Clin Lab; 2023 Mar; 69(3):. PubMed ID: 36912316
[TBL] [Abstract][Full Text] [Related]
3. The use of data independent acquisition based proteomic analysis and machine learning to reveal potential biomarkers for autism spectrum disorder.
Zhang H; Tang X; Feng C; Gao Y; Hong Q; Zhang J; Zhang X; Zheng Q; Lin J; Liu X; Shen L
J Proteomics; 2023 Apr; 278():104872. PubMed ID: 36898611
[TBL] [Abstract][Full Text] [Related]
4. A Proteomics Investigation of Salivary Profiles as Potential Biomarkers for Autism Spectrum Disorder (ASD).
Wormwood KL; Charette L; Ryan JP; Darie CC; Woods AG
Protein J; 2023 Oct; 42(5):607-620. PubMed ID: 37566278
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Proteomic Analysis of Salivary Biomarkers in Autism Spectrum Disorder.
Ngounou Wetie AG; Wormwood KL; Russell S; Ryan JP; Darie CC; Woods AG
Autism Res; 2015 Jun; 8(3):338-50. PubMed ID: 25626423
[TBL] [Abstract][Full Text] [Related]
6. Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study.
Mesleh A; Ehtewish H; de la Fuente A; Al-Shamari H; Ghazal I; Al-Faraj F; Al-Shaban F; Abdesselem HB; Emara M; Alajez NM; Arredouani A; Decock J; Albagha O; Stanton LW; Abdulla SA; El-Agnaf OMA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108604
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children.
West PR; Amaral DG; Bais P; Smith AM; Egnash LA; Ross ME; Palmer JA; Fontaine BR; Conard KR; Corbett BA; Cezar GG; Donley EL; Burrier RE
PLoS One; 2014; 9(11):e112445. PubMed ID: 25380056
[TBL] [Abstract][Full Text] [Related]
8. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.
Khemakhem AM; Frye RE; El-Ansary A; Al-Ayadhi L; Bacha AB
Metab Brain Dis; 2017 Dec; 32(6):1983-1997. PubMed ID: 28831647
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Investigations of Autism Spectrum Disorder: Past Findings, Current Challenges, and Future Prospects.
Abraham J; Szoko N; Natowicz MR
Adv Exp Med Biol; 2019; 1118():235-252. PubMed ID: 30747426
[TBL] [Abstract][Full Text] [Related]
11. Potential protein markers in children with Autistic Spectrum Disorder (ASD) revealed by salivary proteomics.
Mota FSB; Nascimento KS; Oliveira MV; Osterne VJS; Clemente JCM; Correia-Neto C; Lima-Neto AB; van Tilburg MF; Leal-Cardoso JH; Guedes MIF; Cavada BS
Int J Biol Macromol; 2022 Feb; 199():243-251. PubMed ID: 35016969
[TBL] [Abstract][Full Text] [Related]
12. Phospholipidomics of peripheral blood mononuclear cells (PBMCs): the tricky case of children with autism spectrum disorder (ASD) and their healthy siblings.
Ventura G; Calvano CD; Porcelli V; Palmieri L; De Giacomo A; Xu Y; Goodacre R; Palmisano F; Cataldi TRI
Anal Bioanal Chem; 2020 Oct; 412(25):6859-6874. PubMed ID: 32737553
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers in autism spectrum disorders: Current progress.
Shen L; Liu X; Zhang H; Lin J; Feng C; Iqbal J
Clin Chim Acta; 2020 Mar; 502():41-54. PubMed ID: 31857069
[TBL] [Abstract][Full Text] [Related]
14. Altered Metabolic Characteristics in Plasma of Young Boys with Autism Spectrum Disorder.
Wang L; Zheng R; Xu Y; Zhou Z; Guan P; Wu Y; Zhou J; Cheng Z; Zhang L
J Autism Dev Disord; 2022 Nov; 52(11):4897-4907. PubMed ID: 34800227
[TBL] [Abstract][Full Text] [Related]
15. A Metabolomics Approach to Screening for Autism Risk in the Children's Autism Metabolome Project.
Smith AM; Natowicz MR; Braas D; Ludwig MA; Ney DM; Donley ELR; Burrier RE; Amaral DG
Autism Res; 2020 Aug; 13(8):1270-1285. PubMed ID: 32558271
[TBL] [Abstract][Full Text] [Related]
16. Urinary metabolomics using gas chromatography-mass spectrometry: potential biomarkers for autism spectrum disorder.
Khan ZUN; Chand P; Majid H; Ahmed S; Khan AH; Jamil A; Ejaz S; Wasim A; Khan KA; Jafri L
BMC Neurol; 2022 Mar; 22(1):101. PubMed ID: 35300604
[TBL] [Abstract][Full Text] [Related]
17. Blood biomarker discovery for autism spectrum disorder: A proteomic analysis.
Hewitson L; Mathews JA; Devlin M; Schutte C; Lee J; German DC
PLoS One; 2021; 16(2):e0246581. PubMed ID: 33626076
[TBL] [Abstract][Full Text] [Related]
18. Comparative two-dimensional polyacrylamide gel electrophoresis of the salivary proteome of children with autism spectrum disorder.
Ngounou Wetie AG; Wormwood KL; Charette L; Ryan JP; Woods AG; Darie CC
J Cell Mol Med; 2015 Nov; 19(11):2664-78. PubMed ID: 26290361
[TBL] [Abstract][Full Text] [Related]
19. Acyl-carnitine, C5DC, and C26 as potential biomarkers for diagnosis of autism spectrum disorder in children.
Lv QQ; You C; Zou XB; Deng HZ
Psychiatry Res; 2018 Sep; 267():277-280. PubMed ID: 29945069
[TBL] [Abstract][Full Text] [Related]
20. Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.
Khaled EM; Meguid NA; Bjørklund G; Gouda A; Bahary MH; Hashish A; Sallam NM; Chirumbolo S; El-Bana MA
Metab Brain Dis; 2016 Dec; 31(6):1419-1426. PubMed ID: 27406246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
